Liquid biopsy, a minimally invasive procedure, is gaining popularity for cancer detection through screening for biomarkers like cell-free DNA (cfDNA) using next-generation sequencing (NGS). Twist Bioscience has developed the Twist cfDNA Library Preparation Kit to address challenges in sequencing cfDNA, offering higher yields, better coverage, and more sensitive detection of low-frequency variants. The kit has shown significant improvements in performance, especially for detecting circulating tumor DNA (ctDNA), and has been well-received by clinicians and researchers for its efficiency and accuracy in developing sensitive ctDNA assays for oncology research.
Full Article
Deadly Israeli strikes mar fragile Gaza truce
the text you provide. Full Article
Read more